BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 16149064)

  • 1. Combined genome-wide allelotyping and copy number analysis identify frequent genetic losses without copy number reduction in medulloblastoma.
    Langdon JA; Lamont JM; Scott DK; Dyer S; Prebble E; Bown N; Grundy RG; Ellison DW; Clifford SC
    Genes Chromosomes Cancer; 2006 Jan; 45(1):47-60. PubMed ID: 16149064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis.
    Hui AB; Takano H; Lo KW; Kuo WL; Lam CN; Tong CY; Chang Q; Gray JW; Ng HK
    Clin Cancer Res; 2005 Jul; 11(13):4707-16. PubMed ID: 16000565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide amplification and allelotyping of sporadic pituitary adenomas identify novel regions of genetic loss.
    Simpson DJ; Bicknell EJ; Buch HN; Cutty SJ; Clayton RN; Farrell WE
    Genes Chromosomes Cancer; 2003 Jul; 37(3):225-36. PubMed ID: 12759921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supratentorial primitive neuroectodermal tumors of the central nervous system frequently harbor deletions of the CDKN2A locus and other genomic aberrations distinct from medulloblastomas.
    Pfister S; Remke M; Toedt G; Werft W; Benner A; Mendrzyk F; Wittmann A; Devens F; von Hoff K; Rutkowski S; Kulozik A; Radlwimmer B; Scheurlen W; Lichter P; Korshunov A
    Genes Chromosomes Cancer; 2007 Sep; 46(9):839-51. PubMed ID: 17592618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overlay analysis of the oligonucleotide array gene expression profiles and copy number abnormalities as determined by array comparative genomic hybridization in medulloblastomas.
    Lo KC; Rossi MR; Burkhardt T; Pomeroy SL; Cowell JK
    Genes Chromosomes Cancer; 2007 Jan; 46(1):53-66. PubMed ID: 17044047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Array CGH analysis of pediatric medulloblastomas.
    Rossi MR; Conroy J; McQuaid D; Nowak NJ; Rutka JT; Cowell JK
    Genes Chromosomes Cancer; 2006 Mar; 45(3):290-303. PubMed ID: 16320246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide allelic state analysis on flow-sorted tumor fractions provides an accurate measure of chromosomal aberrations.
    Corver WE; Middeldorp A; ter Haar NT; Jordanova ES; van Puijenbroek M; van Eijk R; Cornelisse CJ; Fleuren GJ; Morreau H; Oosting J; van Wezel T
    Cancer Res; 2008 Dec; 68(24):10333-40. PubMed ID: 19074902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization.
    Tong CY; Hui AB; Yin XL; Pang JC; Zhu XL; Poon WS; Ng HK
    J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):187-93. PubMed ID: 14758948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients.
    Pan E; Pellarin M; Holmes E; Smirnov I; Misra A; Eberhart CG; Burger PC; Biegel JA; Feuerstein BG
    Clin Cancer Res; 2005 Jul; 11(13):4733-40. PubMed ID: 16000568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic amplification of orthodenticle homologue 2 in medulloblastomas.
    Boon K; Eberhart CG; Riggins GJ
    Cancer Res; 2005 Feb; 65(3):703-7. PubMed ID: 15705863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex changes and multiple forms of chromosomal instability in colorectal cancers.
    Gaasenbeek M; Howarth K; Rowan AJ; Gorman PA; Jones A; Chaplin T; Liu Y; Bicknell D; Davison EJ; Fiegler H; Carter NP; Roylance RR; Tomlinson IP
    Cancer Res; 2006 Apr; 66(7):3471-9. PubMed ID: 16585170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis.
    Gorringe KL; Ramakrishna M; Williams LH; Sridhar A; Boyle SE; Bearfoot JL; Li J; Anglesio MS; Campbell IG
    Genes Chromosomes Cancer; 2009 Oct; 48(10):931-42. PubMed ID: 19603523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
    Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
    Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular abnormalities in pediatric embryonal brain tumors--analysis of loss of heterozygosity on chromosomes 1, 5, 9, 10, 11, 16, 17 and 22.
    Zakrzewska M; Rieske P; Debiec-Rychter M; Zakrzewski K; Polis L; Fiks T; Liberski PP
    Clin Neuropathol; 2004; 23(5):209-17. PubMed ID: 15581023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sub-megabase resolution tiling (SMRT) array-based comparative genomic hybridization profiling reveals novel gains and losses of chromosomal regions in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma cell lines.
    Fadlelmola FM; Zhou M; de Leeuw RJ; Dosanjh NS; Harmer K; Huntsman D; Lam WL; Banerjee D
    Mol Cancer; 2008 Jan; 7():2. PubMed ID: 18179710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of genetic and chromosomal aberrations in medulloblastomas and primitive neuroectodermal tumors with DNA microarrays.
    Kagawa N; Maruno M; Suzuki T; Hashiba T; Hashimoto N; Izumoto S; Yoshimine T
    Brain Tumor Pathol; 2006 Apr; 23(1):41-7. PubMed ID: 18095118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization.
    Hurst CD; Fiegler H; Carr P; Williams S; Carter NP; Knowles MA
    Oncogene; 2004 Mar; 23(12):2250-63. PubMed ID: 14968109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32.
    Taniguchi T; Karnan S; Fukui T; Yokoyama T; Tagawa H; Yokoi K; Ueda Y; Mitsudomi T; Horio Y; Hida T; Yatabe Y; Seto M; Sekido Y
    Cancer Sci; 2007 Mar; 98(3):438-46. PubMed ID: 17270034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetic studies in medulloblastomas: evidence for tumor suppressor genes at the chromosomal regions 1q31-32 and 17p13.
    Pietsch T; Koch A; Wiestler OD
    Klin Padiatr; 1997; 209(4):150-5. PubMed ID: 9293446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.